GOVX new logo.png
GeoVax Announces Upcoming Presentation of Lassa Fever Vaccine Data
16. Juli 2019 09:00 ET | GeoVax, Inc.
ATLANTA, GA, July 16, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company specializing in developing human vaccines, announced today that Senior...